News
Cheaper alternatives to Ozempic and Wegovy may disappear as FDA reconsiders compounded drug loophole
SHREVEPORT, La. - Many people are using cheaper versions of popular weight-loss shots like Ozempic and Wegovy.
Online prescriptions – for everything from weight loss to medicinal cannabis – is now a big business backed by Woolworths and ...
The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN ...
Novo Nordisk (NVO) is offering a one-month reduction in the price of its blockbuster weight-loss GLP-1 drug, to help ...
An FDA deadline instructing compounding pharmacies and telehealth companies to stop selling compounded versions of Ozempic and Zepbound has not stopped the copycat market, The Wall Street Journal ...
Jamie Dimon's Would-Be Successors Audition for the Top Job at JPMorgan Investors will gather in midtown Manhattan to see who might become the bank's next CEO. Trump Attacks Walmart for Tariff-Related ...
Providers of compounded obesity drugs are finding—for now—a new way into the booming market by tweaking formulations.
Lars Fruergaard Jørgensen will step down after eight years helming the Danish drugmaker, shares of which have shed half their ...
With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...
Hims & Hers Health, Inc.'s Q1 results show 111% growth, yet shares fell 8%. Click for a look at the impact of drug access, competition, and growth sustainability.
GLP-1 is a class of medication that regulates sugar in the body. Examples like Ozempic and Wegovy have typically been prescribed to patients dealing with diabetes and obesity. While the drugs have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results